Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
    Users Online: 132
Home Print this page Email this page Small font size Default font size Increase font size
CASE REPORT
Year : 2021  |  Volume : 10  |  Issue : 2  |  Page : 143-145

Association of headache, anxiety, and depression with the treatment of levetiracetam for epilepsy


1 Department of Pharmacology, Batterjee Medical College, Jeddah, Kingdom of Saudi Arabia
2 Department of Neurology, Jeddah National Hospital, Jeddah, Kingdom of Saudi Arabia
3 Department of Microbiology, Batterjee Medical College, Jeddah, Kingdom of Saudi Arabia
4 Department of Clinical Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia
5 Department of Musculoskeletal and Sports Injury Rehabilitation, Batterjee Medical College, Jeddah, Kingdom of Saudi Arabia

Correspondence Address:
Mohammad Jaffar Mantargi
Department of Pharmacology, Batterjee Medical College, North – Obhur, Jeddah 21442
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjhs.sjhs_234_20

Rights and Permissions

The current case report bears the details of the adverse drug reactions (ADRs) associated after the administration of the levetiracetam for the management of newly diagnosed epilepsy in a female patient aged 37 years. Datum related to the patient, medications and observed ADRs were noted after getting the consent from the patient during which she has explained her experiences after the beginning of the consumption of the said drug. The Naranjo's scale and World Health Organisation, Uppsala Monitoring Centre scales analysis for the assessment of the correctness of the ADR paved for the certainty of the side effect. Drug regimen modification was initiated by the neurologist after the complaints of uneasiness from the patient after which she was identified to be complying with the other medication. Therefore, it can be said that if any patient on antiepileptic medications experiences discomfort, must bring those issues in light as there is always other options available for the management of the epilepsy without delay.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed370    
    Printed18    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal